Category: Clinical Breakthroughs
-
Reducing Blood Cultures and Antibiotics in Pediatrics
Multidisciplinary diagnostic stewardship programs safely decreased blood culture collection and antibiotics for pediatric intensive care patients, according to findings published in JAMA Pediatrics.
-
Dissolving Implantable Device Relieves Pain Without Drugs
A Northwestern University-led team has developed a small, pain-relieving implant that could provide a much-needed alternative to opioids and other highly addictive medications.
-
Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence
A new Northwestern Medicine study found of the new rules issued during a one-year period by the The Joint Commission, many did not appear to be supported by published evidence.
-
Combination Treatment May Improve Quality of Life in Kidney Cancer
Patients with advanced kidney cancer who received a new combination treatment reported improved health-related quality of life outcomes, according to a Northwestern Medicine study.
-
Calcium Channel Blockers May Improve Chemotherapy Response
Calcium channel blockers may improve treatment for patients with pancreatic cancer receiving chemotherapy, according to a recent study.
-
Mixed Results from Prostate Cancer Drug
A new androgen biosynthesis inhibitor drug improved progression-free survival in prostate cancer but did not improve overall survival compared to current therapies.
-
Smart, Dissolving Pacemaker Communicates With Body-Area Sensor and Control Network
A new, smart pacemaker is integrated into a coordinated network of four soft, flexible, wireless, wearable sensors and control units placed around the upper body.
-
Accelerating Cancer Immunology and Immunotherapy Research
The Cancer Immunology and Immunotherapy Initiative at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University is bringing together Feinberg investigators who study immunotherapy to increase collaboration and accelerate high-impact immunotherapy research.
-
Most COVID-19 ‘Long Haulers’ Continue to Experience Symptoms 15 Months After Initial Infection
Most non-hospitalized COVID-19 “long-haulers” at the Northwestern Medicine Neuro COVID-19 Clinic continued to experience symptoms including brain fog, dizziness and fatigue 15 months after disease onset, according to a new study.
-
Blood Test Predicts Response to Immunotherapy
A blood-based tumor biomarker can predict the benefit of immunotherapy to patients with non-small cell lung cancer.
